Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial-Reference-Cited by-同舟云学术

Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial

Published:2023-06 Issue:6 Volume:10 Page:e445-e457
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Alexander Sarah,Aupérin Anne,Bomken Simon,Csóka Monika,Kazanowska Bernarda,Chiang Alan K,Andres Mara,Uyttebroeck Anne,Burke G A Amos,Zsiros József,Pillon Marta,Bollard Catherine M,Mussolin Lara,Verdu-Amoros Jaime,Neven Bénédicte,Barkauskas Donald A,Wheatley Keith,Patte Catherine,Gross Thomas G,Minard-Colin Véronique

Publisher

Elsevier BV

Subject

Hematology

Reference28 articles.

1. Rituximab for high-risk, mature B-cell non-Hodgkin's lymphoma in children;Minard-Colin;N Engl J Med,2020

2. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial;Ribrag;Lancet,2016

3. Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma;Roschewski;J Clin Oncol,2020

4. Diffuse large B-cell lymphoma;Sehn;N Engl J Med,2021

5. Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab;Zhu;Br J Haematol,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance;Current Opinion in Pediatrics;2024-09-03

2. B–NHL Cases in a Tertiary Pediatric Hematology—Oncology Department: A 20-Year Retrospective Cohort Study;Life;2024-05-16

3. Effect of rituximab on immune status in children with aggressive mature B-cell lymphoma/leukemia–a prospective study from CCCG-BNHL-2015;Heliyon;2024-03

4. Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20);BMJ Open;2024-03

5. Extranodal marginal zone lymphoma as the presenting feature of paediatric Sjögren syndrome;Pediatric Blood & Cancer;2023-06-03